Evidence map›Paper›PMID 16901199›Full record

ReviewExpert review of proteomics2006

Photoaffinity labeling combined with mass spectrometric approaches as a tool for structural proteomics.

David Robinette, Nouri Neamati, Kenneth B Tomer, Christoph H Borchers

Abstract readReview
In one paragraph

Review in Expert review of proteomics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Different chemical proteomic approaches to identify the targets of lapatinib.Journal of enzyme inhibition and medicinal chemistry · 2023
    Article
  5. Review
  6. Review
  7. Article
  8. Photocatalytic Modification of Amino Acids, Peptides, and Proteins.Chemistry (Weinheim an der Bergstrasse, Germany) · 2019
    Review
  9. Article
  10. Article
  11. Bioinorganic chemistry and applications · 2018
    Article
  12. Photoaffinity Labeling of the Human AACS medicinal chemistry letters · 2017
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Photocrosslinking approaches to interactome mapping.Current opinion in chemical biology · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David RobinetteUniversity of North Carolina at Chapel Hill, UNC-Duke Proteomics Core Facility, Department of Biochemistry and Biophysics, CB7028, Chapel Hill, NC 27599, USA. robinett@med.unc.edu
Nouri Neamati
Kenneth B Tomer
Christoph H Borchers

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
APPLICATION OF MASS SPECTROMETRY TO STRUCTURAL BIOLOGYZ01ES050127 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI TOMER, KENNETH · 1993 to 2008
$1.8M
STRUCTURAL STUDIES OF HIV PROTEINSZ01ES050150 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI TOMER, KENNETH · 1996 to 2008
$249k
Intramural NIH HHS Z01 ES050150NIAID NIH HHS 9P30 AI050410NIAID NIH HHS P30 AI050410
6 · The paper itself

Abstract

Protein chemistry, such as crosslinking and photoaffinity labeling, in combination with modern mass spectrometric techniques, can provide information regarding protein-protein interactions beyond that normally obtained from protein identification and characterization studies. While protein crosslinking can make tertiary and quaternary protein structure information available, photoaffinity labeling can be used to obtain structural data about ligand-protein interaction sites, such as oligonucleotide-protein, drug-protein and protein-protein interaction. In this article, we describe mass spectrometry-based photoaffinity labeling methodologies currently used and discuss their current limitations. We also discuss their potential as a common approach to structural proteomics for providing 3D information regarding the binding region, which ultimately will be used for molecular modeling and structure-based drug design.

Indexed as

Photoaffinity LabelsAzidesBenzophenonesDiazomethaneLigandsMass SpectrometryModels, MolecularProtein Interaction MappingProteomicsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationUltraviolet RaysAzidesBenzophenonesDiazomethaneLigandsPhotoaffinity Labels

Identifiers

PMID16901199
PMCPMC2266983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.